490 related articles for article (PubMed ID: 33785629)
21. Chlamydia trachomatis Scavenges Host Fatty Acids for Phospholipid Synthesis via an Acyl-Acyl Carrier Protein Synthetase.
Yao J; Dodson VJ; Frank MW; Rock CO
J Biol Chem; 2015 Sep; 290(36):22163-73. PubMed ID: 26195634
[TBL] [Abstract][Full Text] [Related]
22. Chlamydia trachomatis Plasmid Gene Protein 3 Is Essential for the Establishment of Persistent Infection and Associated Immunopathology.
Yang C; Kari L; Lei L; Carlson JH; Ma L; Couch CE; Whitmire WM; Bock K; Moore I; Bonner C; McClarty G; Caldwell HD
mBio; 2020 Aug; 11(4):. PubMed ID: 32817110
[No Abstract] [Full Text] [Related]
23. Damage/Danger Associated Molecular Patterns (DAMPs) Modulate Chlamydia pecorum and C. trachomatis Serovar E Inclusion Development In Vitro.
Leonard CA; Schoborg RV; Borel N
PLoS One; 2015; 10(8):e0134943. PubMed ID: 26248286
[TBL] [Abstract][Full Text] [Related]
24. Plasmid Negative Regulation of CPAF Expression Is Pgp4 Independent and Restricted to Invasive
Patton MJ; Chen CY; Yang C; McCorrister S; Grant C; Westmacott G; Yuan XY; Ochoa E; Fariss R; Whitmire WM; Carlson JH; Caldwell HD; McClarty G
mBio; 2018 Jan; 9(1):. PubMed ID: 29382731
[No Abstract] [Full Text] [Related]
25. Reprogramming of host glutamine metabolism during Chlamydia trachomatis infection and its key role in peptidoglycan synthesis.
Rajeeve K; Vollmuth N; Janaki-Raman S; Wulff TF; Baluapuri A; Dejure FR; Huber C; Fink J; Schmalhofer M; Schmitz W; Sivadasan R; Eilers M; Wolf E; Eisenreich W; Schulze A; Seibel J; Rudel T
Nat Microbiol; 2020 Nov; 5(11):1390-1402. PubMed ID: 32747796
[TBL] [Abstract][Full Text] [Related]
26. Bactericidal activity of first-choice antibiotics against gamma interferon-induced persistent infection of human epithelial cells by Chlamydia trachomatis.
Reveneau N; Crane DD; Fischer E; Caldwell HD
Antimicrob Agents Chemother; 2005 May; 49(5):1787-93. PubMed ID: 15855497
[TBL] [Abstract][Full Text] [Related]
27. Activation of neutrophils by Chlamydia trachomatis-infected epithelial cells is modulated by the chlamydial plasmid.
Lehr S; Vier J; Häcker G; Kirschnek S
Microbes Infect; 2018 May; 20(5):284-292. PubMed ID: 29499390
[TBL] [Abstract][Full Text] [Related]
28. Early Transcriptional Landscapes of
Hayward RJ; Marsh JW; Humphrys MS; Huston WM; Myers GSA
Front Cell Infect Microbiol; 2019; 9():392. PubMed ID: 31803632
[No Abstract] [Full Text] [Related]
29. Host cell phospholipids are trafficked to and then modified by Chlamydia trachomatis.
Wylie JL; Hatch GM; McClarty G
J Bacteriol; 1997 Dec; 179(23):7233-42. PubMed ID: 9393685
[TBL] [Abstract][Full Text] [Related]
30. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937).
Mpiga P; Ravaoarinoro M
Int J Antimicrob Agents; 2006 Apr; 27(4):316-24. PubMed ID: 16527461
[TBL] [Abstract][Full Text] [Related]
31. Host immune responses after hypoxic reactivation of IFN-γ induced persistent Chlamydia trachomatis infection.
Jerchel S; Kaufhold I; Schuchardt L; Shima K; Rupp J
Front Cell Infect Microbiol; 2014; 4():43. PubMed ID: 24783060
[TBL] [Abstract][Full Text] [Related]
32. Fosmidomycin, an inhibitor of isoprenoid synthesis, induces persistence in Chlamydia by inhibiting peptidoglycan assembly.
Slade JA; Brockett M; Singh R; Liechti GW; Maurelli AT
PLoS Pathog; 2019 Oct; 15(10):e1008078. PubMed ID: 31622442
[TBL] [Abstract][Full Text] [Related]
33. Antimicrobial Resistance Screening in Chlamydia trachomatis by Optimized McCoy Cell Culture System and Direct qPCR-Based Monitoring of Chlamydial Growth.
Meštrović T; Virok DP; Ljubin-Sternak S; Raffai T; Burián K; Vraneš J
Methods Mol Biol; 2019; 2042():33-43. PubMed ID: 31385269
[TBL] [Abstract][Full Text] [Related]
34. Serotonin and melatonin, neurohormones for homeostasis, as novel inhibitors of infections by the intracellular parasite chlamydia.
Rahman MA; Azuma Y; Fukunaga H; Murakami T; Sugi K; Fukushi H; Miura K; Suzuki H; Shirai M
J Antimicrob Chemother; 2005 Nov; 56(5):861-8. PubMed ID: 16172105
[TBL] [Abstract][Full Text] [Related]
35. A novel protease inhibitor causes inclusion vacuole reduction and disrupts the intracellular growth of Chlamydia trachomatis.
Zhou Y; Lu X; Huang D; Lu Y; Zhang H; Zhang L; Yu P; Wang F; Wang Y
Biochem Biophys Res Commun; 2019 Aug; 516(1):157-162. PubMed ID: 31202460
[TBL] [Abstract][Full Text] [Related]
36. Chlamydia trachomatis genes whose products are related to energy metabolism are expressed differentially in active vs. persistent infection.
Gérard HC; Freise J; Wang Z; Roberts G; Rudy D; Krauss-Opatz B; Köhler L; Zeidler H; Schumacher HR; Whittum-Hudson JA; Hudson AP
Microbes Infect; 2002 Jan; 4(1):13-22. PubMed ID: 11825770
[TBL] [Abstract][Full Text] [Related]
37. Synovial Chlamydia trachomatis up regulates expression of a panel of genes similar to that transcribed by Mycobacterium tuberculosis during persistent infection.
Gérard HC; Whittum-Hudson JA; Schumacher HR; Hudson AP
Ann Rheum Dis; 2006 Mar; 65(3):321-7. PubMed ID: 16192289
[TBL] [Abstract][Full Text] [Related]
38. Metabolic dormancy in
Rockey DD; Wang X; Debrine A; Grieshaber N; Grieshaber SS
Infect Immun; 2024 Feb; 92(2):e0033923. PubMed ID: 38214508
[TBL] [Abstract][Full Text] [Related]
39. Effect of clinically relevant culture conditions on antimicrobial susceptibility of Chlamydia trachomatis.
Wyrick PB; Davis CH; Raulston JE; Knight ST; Choong J
Clin Infect Dis; 1994 Nov; 19(5):931-6. PubMed ID: 7893882
[TBL] [Abstract][Full Text] [Related]
40. Effect of Ureaplasma parvum co-incubation on Chlamydia trachomatis maturation in human epithelial HeLa cells treated with interferon-γ.
Yamazaki T; Matsuo J; Nakamura S; Oguri S; Yamaguchi H
J Infect Chemother; 2014 Aug; 20(8):460-4. PubMed ID: 24855914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
